HaystackAnalytics is a precision diagnostics and clinical genomics company that leverages Next-Generation Sequencing (NGS), bioinformatics, and artificial intelligence to transform disease diagnosis and personalized healthcare. The company's portfolio includes genomic solutions for infectious disease detection, antimicrobial resistance profiling, inherited disease testing, and pharmacogenomics. Through its healthcare
identifi, a product of HaystackAnalytics, is a clinical genomics platform that uses Next-Generation Sequencing (NGS) to provide genetic testing for inherited diseases and pharmacogenomics. It supports early diagnosis, disease risk assessment, precision treatment, and preventive healthcare. Designed for healthcare professionals and individuals, identifi makes genomic testing more accessible, affordable, and actionable
infexn® is an advanced Next-Generation Sequencing (NGS)-based infectious disease diagnostic platform developed by HaystackAnalytics to help clinicians rapidly identify the cause of infections with greater accuracy than conventional diagnostic methods. Designed for hospitals and diagnostic laboratories, infexn® enables comprehensive detection of bacteria, fungi, major respiratory and neuropathic viruses, and a
Copyright © 2024 Digital Marketing Deal. All rights reserved.
